The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
Open accessAbstract
In pharmacovigilance, disproportionality analyses based on individual case safety reports are widely used to detect safety signals. Unfortunately, publishing disproportionality analyses lacks specific guidelines, often leading to incomplete and ambiguous reporting, and carries the risk of incorrect conclusions when data are not placed in the correct context. The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV) statement was developed to address this issue by promoting transparent and comprehensive reporting of disproportionality studies. While the statement paper explains in greater detail the procedure followed to develop these guidelines, with this explanation paper we present the 14 items retained for READUS-PV guidelines, together with an in-depth explanation of their rationale and bullet points to illustrate their practical implementation. Our primary objective is to foster the adoption of the READUS-PV guidelines among authors, editors, peer reviewers, and readers of disproportionality analyses. Enhancing transparency, completeness, and accuracy of reporting, as well as proper interpretation of their results, READUS-PV guidelines will ultimately facilitate evidence-based decision making in pharmacovigilance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Avoidable waste in the production and reporting of research evidence
Chalmers, I., & Glasziou, P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60329-9 · Cited by 2,208
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
A Bayesian neural network method for adverse drug reaction signal generation
Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050466 · Cited by 1,476
Self-citationGuidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437
The Medical Dictionary for Regulatory Activities (MedDRA)
Brown, E. G., Wood, L., & Wood, S. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00002 · Cited by 1,390
Reducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Conducting systematic reviews of association (etiology): The Joanna Briggs Institute's approach
Moola, S., Munn, Z., Sears, K., Sfetcu, R., Currie, M., Lisy, K., Tufanaru, C., Qureshi, R., Mattis, P., & Mu, P. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000064 · Cited by 849
Developing the Review Question and Inclusion Criteria
Stern, C., Jordan, Z., & McArthur, A. (2014) · AJN, American Journal of Nursing · doi:10.1097/01.naj.0000445689.67800.86 · Cited by 629
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0553-2 · Cited by 616
Self-citationMontastruc, J., Sommet, A., Bagheri, H., & Lapeyre‐Mestre, M. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04037.x · Cited by 517
Case-non-case studies: principle, methods, bias and interpretation
Faillie, J.-L. (2019) · Therapies · doi:10.1016/j.therap.2019.01.006 · Cited by 336
Self-citationHarpaz, R., DuMouchel, W., LePendu, P., Bauer-Mehren, A., Ryan, P., & Shah, N. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.24 · Cited by 333
Misrepresentation and distortion of research in biomedical literature
Boutron, I., & Ravaud, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710755115 · Cited by 273
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01421-9 · Cited by 270
Self-citationPariente, A., Gregoire, F., Fourrier-Reglat, A., Haramburu, F., & Moore, N. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00007 · Cited by 268
Self-citationAnti-HERG activity and the risk of drug-induced arrhythmias and sudden death
De Bruin, M. L., Pettersson, M., Meyboom, R. H. B., Hoes, A. W., & Leufkens, H. G. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi092 · Cited by 245
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Cutroneo, P. M., Sartori, D., Tuccori, M., Crisafulli, S., Battini, V., Carnovale, C., Rafaniello, C., Capuano, A., Poluzzi, E., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2023.1323057 · Cited by 224
Self-citationA statistical methodology for drug–drug interaction surveillance
Norén, G. N., Sundberg, R., Bate, A., & Edwards, I. R. (2008) · Statistics in Medicine · doi:10.1002/sim.3247 · Cited by 199
Self-citationAbeijon, P., Costa, C., Taracido, M., Herdeiro, M. T., Torre, C., & Figueiras, A. (2023) · Drug Safety · doi:10.1007/s40264-023-01302-7 · Cited by 161
Self-citationGood Signal Detection Practices: Evidence from IMI PROTECT
Wisniewski, A. F. Z., Bate, A., Cédric Bousquet, B., Brueckner, A., Candore, G., Juhlin, K., Maciá, M. A., Manlik, K., Quarcoo, N., Seabroke, S., et al. (2016) · Drug Safety · doi:10.1007/s40264-016-0405-1 · Cited by 152
Self-citationComparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases
Candore, G., Juhlin, K., Manlik, K., Thakrar, B. T., Quarcoo, N., Seabroke, S., Wisniewski, A. F. Z., & Slattery, J. (2015) · Drug Safety · doi:10.1007/s40264-015-0289-5 · Cited by 151
Self-citationDuplicate detection in adverse drug reaction surveillance
Norén, G. N., Orre, R., Bate, A., & Edwards, I. R. (2007) · Data Mining and Knowledge Discovery · doi:10.1007/s10618-006-0052-8 · Cited by 144
Self-citationCausal Association in Pharmacovigilance and Pharmacoepidemiology
Shakir, S., & Layton, D. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00012 · Cited by 122
Raschi, E., Poluzzi, E., Salvo, F., Pariente, A., De Ponti, F., Marchesini, G., & Moretti, U. (2018) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.014 · Cited by 119
Self-citationNoguchi, Y., Tachi, T., & Teramachi, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01319 · Cited by 109
Self-citationAdverse drug event reporting systems: a systematic review
Bailey, C., Peddie, D. J., Wickham, M. E., Badke, K., Small, S. S., Doyle‐Waters, M. M., Balka, E., & Hohl, C. M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12944 · Cited by 108
Comparison of different methods for causality assessment of adverse drug reactions
Behera, S. K., Das, S., Xavier, A. S., Velupula, S., & Selvarajan, S. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0694-9 · Cited by 102
Khouri, C., Petit, C., Tod, M. M., Lepelley, M., Revol, B., Roustit, M., & Cracowski, J. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.01.015 · Cited by 86
Self-citationInvestigating Overlap in Signals from EVDAS, FAERS, and VigiBase®
Vogel, U., van Stekelenborg, J., Dreyfus, B., Garg, A., Habib, M., Hosain, R., & Wisniewski, A. F. Z. (2020) · Drug Safety · doi:10.1007/s40264-019-00899-y · Cited by 85
Influence of the MedDRA® hierarchy on pharmacovigilance data mining results
Pearson, R. K., Hauben, M., Goldsmith, D. I., Gould, A. L., Madigan, D., O’Hara, D. J., Reisinger, S. J., & Hochberg, A. M. (2009) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2009.01.001 · Cited by 70
Self-citationDeterminants of signal selection in a spontaneous reporting system for adverse drug reactions
van Puijenbroek, E., van Grootheest, K., Diemont, W. L., Leufkens, H. G. M., & Egberts, T. C. G. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01501.x · Cited by 68
Fusaroli, M., Isgrò, V., Cutroneo, P. M., Ferrajolo, C., Cirillo, V., Bufalo, F. D., Raschi, E., Poluzzi, E., & Trifirò, G. (2022) · Drug Safety · doi:10.1007/s40264-022-01194-z · Cited by 66
Self-citationMaciá, M. A., de Abajo, F. J., Roberts, G., Slattery, J., Thakrar, B. T., & Wisniewski, A. F. Z. (2015) · Drug Safety · doi:10.1007/s40264-015-0351-3 · Cited by 65
Data Mining in Pharmacovigilance
Hauben, M., Patadia, V. K., Gerrits, C. M., Walsh, L., & Reich, L. (2005) · Drug Safety · doi:10.2165/00002018-200528100-00001 · Cited by 64
Self-citationSandberg, L., Taavola, H., Aoki, Y., Chandler, R. E., & Norén, G. N. (2020) · Drug Safety · doi:10.1007/s40264-020-00957-w · Cited by 63
Self-citationPerformance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases
Seabroke, S., Candore, G., Juhlin, K., Quarcoo, N., Wisniewski, A. F. Z., Arani, R. B., Painter, J. L., Tregunno, P. M., Norén, G. N., & Slattery, J. (2016) · Drug Safety · doi:10.1007/s40264-015-0388-3 · Cited by 60
Self-citationConsiderations on the use of different comparators in pharmacovigilance: A methodological review
Gravel, C. A., & Douros, A. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15802 · Cited by 60
Perrio, M. J., Voss, S., & Shakir, S. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00006 · Cited by 58
Fukazawa, C., Hinomura, Y., Kaneko, M., & Narukawa, M. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4672 · Cited by 57
Pham, M., Cheng, F., & Ramachandran, K. M. (2019) · Drug Safety · doi:10.1007/s40264-018-00792-0 · Cited by 57
Mouffak, A., Lepelley, M., Revol, B., Bernardeau, C., Salvo, F., Pariente, A., Roustit, M., Cracowski, J., & Khouri, C. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.06.022 · Cited by 54
Self-citationGiunchi, V., Fusaroli, M., Hauben, M., Raschi, E., & Poluzzi, E. (2023) · Drug Safety · doi:10.1007/s40264-023-01345-w · Cited by 52
Self-citationEvolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety
Raschi, E., Moretti, U., Salvo, F., Pariente, A., Antonazzo, I. C., Ponti, F. D., & Poluzzi, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79986 · Cited by 51
Self-citationKhouri, C., Revol, B., Lepelley, M., Mouffak, A., Bernardeau, C., Salvo, F., Pariente, A., Roustit, M., & Cracowski, J. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.07.014 · Cited by 51
Self-citationKhouri, C., Nguyen, T., Revol, B., Lepelley, M., Pariente, A., Roustit, M., & Cracowski, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668765 · Cited by 46
Self-citationFusaroli, M., Raschi, E., Giunchi, V., Menchetti, M., Rimondini, R., Ponti, F. D., & Poluzzi, E. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac031 · Cited by 44
Self-citationNguyen, T. T. H., Pariente, A., Montastruc, J., Lapeyre‐Mestre, M., Rousseau, V., Rascol, O., Bégaud, B., & Montastruc, F. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13145 · Cited by 43
Self-citationAn evaluation of statistical approaches to postmarketing surveillance
Ding, Y., Markatou, M., & Ball, R. (2020) · Statistics in Medicine · doi:10.1002/sim.8447 · Cited by 42
When to publish measures of disproportionality derived from spontaneous reporting databases?
de Boer, A. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04087.x · Cited by 41
Sartori, D., Aronson, J. K., Norén, G. N., & Onakpoya, I. (2022) · Drug Safety · doi:10.1007/s40264-022-01258-0 · Cited by 41
Self-citationAssociation Between Data Sources and US Food and Drug Administration Drug Safety Communications
Tau, N., Shochat, T., Gafter‐Gvili, A., Tibau, A., Amir, E., & Shepshelovich, D. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3066 · Cited by 35
Fusaroli, M., Giunchi, V., Battini, V., Gringeri, M., Rimondini, R., Menchetti, M., Radice, S., Pozzi, M., Nobile, M., Clementi, E., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13511 · Cited by 33
Self-citationMansmann, U., Locher, C., Praßer, F., Weissgerber, T. L., Sax, U., Posch, M., Decullier, É., Cristea, I. A., Debray, T. P. A., Held, L., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02080-y · Cited by 32
Reich, C., Ryan, P. B., & Schuemie, M. J. (2013) · Drug Safety · doi:10.1007/s40264-013-0111-1 · Cited by 31
Gauffin, O., Brand, J. S., Vidlin, S. H., Sartori, D., Asikainen, S., Català, M., Chalabi, E., Dedman, D., Danilović, A., Duarte‐Salles, T., et al. (2023) · Drug Safety · doi:10.1007/s40264-023-01353-w · Cited by 29
Self-citationEffect of Date of Drug Marketing on Disproportionality Measures in Pharmacovigilance
Pariente, A., Daveluy, A., Bénard‐Laribière, A., Miremont‐Salamé, G., Bégaud, B., & Moore, N. D. (2009) · Drug Safety · doi:10.2165/00002018-200932050-00007 · Cited by 27
Self-citationVisualizations throughout pharmacoepidemiology study planning, implementation, and reporting
Gatto, N. M., Wang, S. V., Murk, W. K., Mattox, P. W., Brookhart, M. A., Bate, A., Schneeweiß, S., & Rassen, J. A. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5529 · Cited by 26
Self-citationInterpretation of Pharmacovigilance Disproportionality Analyses
Khouri, C., Fusaroli, M., Salvo, F., & Raschi, E. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2951 · Cited by 26
Self-citationRaschi, E., Salvo, F., & Khouri, C. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15269 · Cited by 21
Self-citationFusaroli, M., Salvo, F., Bernardeau, C., Idris, M., Dolladille, C., Pariente, A., Poluzzi, E., Raschi, E., & Khouri, C. (2023) · Drug Safety · doi:10.1007/s40264-023-01329-w · Cited by 21
Self-citationSultana, J., Hurtado, I., Bejarano‐Quisoboni, D., Giorgianni, F., Huybrechts, K. F., Lu, Z., Patorno, E., Sanfélix‐Gimeno, G., Tari, D. U., & Trifirò, G. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02654-9 · Cited by 18
New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms?
Loke, Y. K., Mattishent, K., & Navaneetharaja, N. (2024) · Pharmacy · doi:10.3390/pharmacy12010033 · Cited by 18
Fusaroli, M., Raschi, E., Gatti, M., Ponti, F. D., & Poluzzi, E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740707 · Cited by 15
Self-citationModgill, V., Dormegny, L., & Lewis, D. J. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14342 · Cited by 12
Mahaux, O., Powell, G. E., Haguinet, F., Sobczak, P., Saini, N., Barry, A., Mustafa, A., & Bate, A. (2023) · Drug Safety · doi:10.1007/s40264-023-01306-3 · Cited by 11
Self-citationInvestigating the link between drug consumption and adverse events reporting in France
Orhon, P., Robert, M., Morand, T., Cracowski, J., & Khouri, C. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12893 · Cited by 6
Self-citationMoore, N. (2011) · BMJ · doi:10.1136/bmj.d2732 · Cited by 5
Raschi, E., Salvo, F., Plaça, M. L., Poluzzi, E., & Ponti, F. D. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16379 · Cited by 5
Self-citationValidity, relevance and interpretation of pharmacovigilance disproportionality analyses
Cortes, B., Jambon-Barbara, C., Cracowski, J., & Khouri, C. (2023) · Bone · doi:10.1016/j.bone.2023.116685 · Cited by 5
Self-citation
Cited by
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01421-9 · Cited by 270
Self-citationSchoretsanitis, G., Weiler, S., Barbui, C., Raschi, E., & Gastaldon, C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.23385 · Cited by 107
Self-citation
Metadata
- Authors
- Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M.-D., Faillie, J.-L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., Montastruc, F., Noguchi, Y., Norén, G. N., Noseda, R., Onakpoya, I. J., Pariente, A., Poluzzi, E., Salem, M., Sartori, D., Trinh, N. T. H., Tuccori, M., van Hunsel, F., van Puijenbroek, E., Raschi, E., & Khouri, C.
- Venue
- Drug Safety
- Published
- 2024-05-07
- Volume
- 47
- Issue
- 6
- Pages
- 585-599
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W4396696102
- Cited by
- 351
- References
- 72
- FWCI
- 268.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.